Abstract
The licensing system is the chief novel feature of the Act, and lies at the heart of all of the control over medicines. The system is designed to ensure that medicinal products (and certain other substances and articles) are of good quality, safe and efficacious and are manufactured and dealt with under optimal conditions. The system also enables batches of products to be traced and withdrawn from sale with the minimum of delay should they prove subsequently to be defective in any respect. This is achieved by a system of batch numbers and records kept by manufacturers and wholesalers. The system utilises three types of licence and two types of certificate each of which permits a person (including a ‘legal person’, e.g. a company) to engage in certain specified activities. It may therefore be necessary for a company to hold two or even three types of licence in certain cases. A fee is normally payable for each licence. It is an offence to engage in any of the controlled activities unless one holds the appropriate licence(s) (section 45(1)).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
B.P. Commission Annual Report for 1976, paragraph
Hartley and Maynard (1982). The costs and benefits of regulating new product development in the UK pharmaceutical industry. (London: OHE)
MAIL No. 40, p.4
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1986 MTP Press Limited
About this chapter
Cite this chapter
Harrison, I.H. (1986). The Licensing System. In: The Law on Medicines. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4141-0_4
Download citation
DOI: https://doi.org/10.1007/978-94-009-4141-0_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8337-9
Online ISBN: 978-94-009-4141-0
eBook Packages: Springer Book Archive